70069-830-01 : NDC 2026 Code

70069-830-01 : Dalbavancin ( Dalbavancin )

Additionally :

You can get information about “70069-830-01” NDC code in 70069-830-01 in HTML format

HTML | 70069-830-01 in TXT (Plain Text) format

TXT | 70069-830-01 in PDF (Portable Document Format)

PDF | 70069-830-01 in XML format

XML formats.

NDC Code : 70069-830-01 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "70069-830-01",
    "PackageDescription": "1 VIAL in 1 CARTON (70069-830-01)  / 25 mL in 1 VIAL",
    "NDC11Code": "70069-0830-01",
    "ProductNDC": "70069-830",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Dalbavancin",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Dalbavancin",
    "DosageFormName": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20260727",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA219604",
    "LabelerName": "Somerset Therapeutics, LLC",
    "SubstanceName": "DALBAVANCIN HYDROCHLORIDE",
    "StrengthNumber": "500",
    "StrengthUnit": "mg/25mL",
    "Pharm_Classes": "Lipoglycopeptide Antibacterial [EPC], Lipoglycopeptides [CS]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-07-29",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20260727",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}